2022. Angiotensin Receptor Blockers (ARB) and its Impact on the Risk of Mortality in COVID-19 Patients with Hypertension: A Meta-Analysis. The International Conference on Public Health Proceeding. 7, 01 (Nov. 2022), 46. DOI:https://doi.org/10.26911/AB.ICPH.09.2022.46.